Friday, 16 October 2026European Markets

WERELDHAVE BELGIUM And SELECTIRENTE Have A High Dividend Yield And Return On Equity In The REIT—Retail Industry.

Loading stream...

(vianews) - wereldhave belgium (wehb.br) is among this list of stock assets with the highest dividend rate and return on equity on the reit—retail industry.

financial asset price forward dividend yield return on equity
wereldhave belgium (wehb.br) €54.50 7.59% 8.05%
selectirente (seler.pa) €99.00 3.64% 3.59%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. wereldhave belgium (wehb.br)

7.59% forward dividend yield and 8.05% return on equity

wereldhave belgium focuses on shopping centres and retail parks that are dominant in their catchment area. the shares are listed on the euronext brussels stock exchange. on 31 march 2020, wereldhave belgium's market capitalisation amounts to € 403 million.

earnings per share

as for profitability, wereldhave belgium has a trailing twelve months eps of €-2.81.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 8.05%.

more news about wereldhave belgium.

2. selectirente (seler.pa)

3.64% forward dividend yield and 3.59% return on equity

selectirente is a public real estate fund managed by sofidy. it invests in city center and suburb commercial properties, which should be located close to shopping malls. it primarily acquires properties in france. as of march 29, 2019, selectirente operates as a subsidiary of tikehau capital.

earnings per share

as for profitability, selectirente has a trailing twelve months eps of €2.62.

pe ratio

selectirente has a trailing twelve months price to earnings ratio of 37.83. meaning, the purchaser of the share is investing €37.83 for every euro of annual earnings.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 3.59%.

dividend yield

as claimed by morningstar, inc., the next dividend payment is on jun 10, 2022, the estimated forward annual dividend rate is 3.6 and the estimated forward annual dividend yield is 3.64%.

stock price classification

according to the stochastic oscillator, a useful indicator of overbought and oversold conditions, selectirente's stock is considered to be overbought (>=80).

volume

today's last reported volume for selectirente is 2 which is 71.42% below its average volume of 7.

revenue growth

year-on-year quarterly revenue growth grew by 25.8%, now sitting on 32.7m for the twelve trailing months.

more news about selectirente.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,378 source documents archived
Query this data → isubstrate.com